Results 281 to 290 of about 17,850,454 (351)
A HER3‐targeted sonogenetic lipid nanoparticle platform is developed for triple‐negative breast cancer therapy. An AI‐designed miniprotein inhibits HER3 signaling, while TRPV4 and NFAT‐responsive IL‐15 plasmids enable ultrasound‐controlled calcium signaling and cytokine expression. The system induces Ca2+ overload, ROS generation, mitochondrial damage,
Junya Song +6 more
wiley +1 more source
Is chronic venous disease a marker of systemic cardiovascular risk? A systematic review. [PDF]
Boneva B, Dimova M, Ilchev B.
europepmc +1 more source
The Deubiquitinase UCHL1 Drives Susceptibility to Atrial Fibrillation by Stabilizing CaMKII‐δ
UCHL1 is highly upregulated in mice and patients with AF. UCHL1 directly binds to and removes K48‐linked polyubiquitin chains from CaMKII‐δ at K251 and enhances CaMKII‐δ stability, which activates RyR2, disrupts Ca2+ handling, and promotes AF. These findings establish UCHL1 as a critical regulator of CaMKII‐δ stability and AF‐related Ca2+ handling ...
Hai‐Lian Bi +6 more
wiley +1 more source
Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis: An External Validation in the BRASS Registry. [PDF]
Paudel ML +10 more
europepmc +1 more source
Is There a Problem with The PREVENT Cardiovascular Risk Model? [PDF]
Atıcı Y, Şen MB, Yücel D.
europepmc +1 more source
Preterm Birth and Maternal Cardiovascular Risk. [PDF]
Segovia-Reyes J +5 more
europepmc +1 more source
Sex, Sex Hormones and Inflammatory Burden and Cardiovascular Risk in Patients with Spondyloarthritis. [PDF]
Cheng IT, Meng H, So H, Tam LS.
europepmc +1 more source
Advances in cardiovascular risk assessment indicators in obstructive sleep apnea. [PDF]
Feng T, Liu Y, Yue Y, Zeng C, Feng Y.
europepmc +1 more source

